Form 4: Vigil Neuroscience Director Acquires Stock Options

Samantha L. Budd Haeberlein, a director at Vigil Neuroscience, Inc., was granted stock options for 18,068 shares on June 5, 2024.

Summary

• On June 5, 2024, Samantha L. Budd Haeberlein, a director of Vigil Neuroscience, Inc., acquired stock options for 18,068 shares.
• The options were granted under the company's 2021 Stock Option and Incentive Plan.
• The exercise price of the options is $3.38 per share.
• The options vest and become exercisable on the earlier of June 5, 2025, or the next annual meeting of the Issuer's stockholders.
• The options expire on June 5, 2034.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard regulatory filing regarding stock option grants.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.

Future Outlook

NA

Industry Context

This is a routine disclosure of insider transactions, common in publicly traded companies to ensure transparency and compliance with securities regulations.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment as it aligns the director's interests with those of the shareholders.

Key Dates